Myeco Group Past Earnings Performance
Past criteria checks 0/6
Myeco Group's earnings have been declining at an average annual rate of -39.5%, while the Chemicals industry saw earnings growing at 8.8% annually. Revenues have been declining at an average rate of 3.6% per year.
Key information
-39.5%
Earnings growth rate
-22.0%
EPS growth rate
| Chemicals Industry Growth | 14.4% |
| Revenue growth rate | -3.6% |
| Return on equity | -67.2% |
| Net Margin | -65.2% |
| Last Earnings Update | 30 Jun 2024 |
Recent past performance updates
Recent updates
Revenues Working Against SECOS Group Limited's (ASX:SES) Share Price Following 26% Dive
Jul 14
Lacklustre Performance Is Driving SECOS Group Limited's (ASX:SES) 27% Price Drop
Dec 27There's No Escaping SECOS Group Limited's (ASX:SES) Muted Revenues
Jun 17Here's Why We're Not At All Concerned With SECOS Group's (ASX:SES) Cash Burn Situation
Mar 02Here's Why We're Not Too Worried About SECOS Group's (ASX:SES) Cash Burn Situation
Nov 01What Does SECOS Group Limited's (ASX:SES) Share Price Indicate?
Jul 15One SECOS Group Limited (ASX:SES) Broker Just Cut Their Revenue Forecasts By 10%
Feb 28SECOS Group (ASX:SES) Might Have The Makings Of A Multi-Bagger
Oct 05We Think Shareholders Should Be Aware Of Some Factors Beyond SECOS Group's (ASX:SES) Profit
Sep 02We Think SECOS Group (ASX:SES) Can Easily Afford To Drive Business Growth
Jun 07We Might See A Profit From SECOS Group Limited (ASX:SES) Soon
Apr 06Imagine Holding SECOS Group (ASX:SES) Shares While The Price Zoomed 409% Higher
Mar 15Should You Think About Buying SECOS Group Limited (ASX:SES) Now?
Feb 22Richard Tegoni Is The Executive Chairman of SECOS Group Limited (ASX:SES) And They Just Picked Up 63% More Shares
Feb 05
Read This Before Buying SECOS Group Limited (ASX:SES) Shares
Jan 19If You Had Bought SECOS Group (ASX:SES) Stock Three Years Ago, You Could Pocket A 100% Gain Today
Dec 15SECOS Group Limited (ASX:SES) Insiders Increased Their Holdings
Aug 11Breakeven On The Horizon For SECOS Group Limited (ASX:SES)
Aug 11Revenue & Expenses Breakdown
How Myeco Group makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
| Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
|---|---|---|---|---|
| 30 Jun 24 | 14 | -9 | 7 | 0 |
| 31 Mar 24 | 14 | -8 | 7 | 0 |
| 31 Dec 23 | 21 | -7 | 8 | 0 |
| 30 Sep 23 | 22 | -7 | 8 | 0 |
| 30 Jun 23 | 16 | -6 | 7 | 0 |
| 31 Mar 23 | 20 | -6 | 6 | 0 |
| 31 Dec 22 | 23 | -5 | 6 | 0 |
| 30 Sep 22 | 27 | -4 | 6 | 0 |
| 30 Jun 22 | 31 | -3 | 6 | 0 |
| 31 Mar 22 | 31 | -1 | 5 | 0 |
| 31 Dec 21 | 32 | 2 | 5 | 0 |
| 30 Sep 21 | 31 | 2 | 5 | 0 |
| 30 Jun 21 | 30 | 3 | 4 | 0 |
| 31 Mar 21 | 27 | 1 | 4 | 0 |
| 31 Dec 20 | 24 | 0 | 4 | 0 |
| 30 Sep 20 | 23 | -1 | 4 | 0 |
| 30 Jun 20 | 21 | -1 | 4 | 0 |
| 31 Mar 20 | 21 | -2 | 4 | 0 |
| 31 Dec 19 | 21 | -2 | 4 | 0 |
| 30 Sep 19 | 21 | -3 | 5 | 0 |
| 30 Jun 19 | 21 | -4 | 6 | 0 |
| 31 Mar 19 | 22 | -4 | 6 | 0 |
| 31 Dec 18 | 23 | -4 | 6 | 0 |
| 30 Sep 18 | 23 | -4 | 6 | 0 |
| 30 Jun 18 | 24 | -3 | 6 | 0 |
| 31 Mar 18 | 23 | -3 | 5 | 0 |
| 31 Dec 17 | 23 | -3 | 5 | 0 |
| 30 Sep 17 | 23 | -3 | 5 | 0 |
| 30 Jun 17 | 22 | -3 | 5 | 0 |
| 31 Dec 16 | 21 | -4 | 5 | 0 |
| 30 Sep 16 | 21 | -4 | 5 | 0 |
| 30 Jun 16 | 21 | -5 | 5 | 0 |
| 31 Dec 15 | 19 | -4 | 4 | 1 |
| 30 Sep 15 | 18 | -4 | 3 | 0 |
| 30 Jun 15 | 17 | -3 | 3 | 0 |
| 30 Jun 14 | 21 | -2 | 2 | 0 |
Quality Earnings: MCO is currently unprofitable.
Growing Profit Margin: MCO is currently unprofitable.
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: MCO is unprofitable, and losses have increased over the past 5 years at a rate of 39.5% per year.
Accelerating Growth: Unable to compare MCO's earnings growth over the past year to its 5-year average as it is currently unprofitable
Earnings vs Industry: MCO is unprofitable, making it difficult to compare its past year earnings growth to the Chemicals industry (3.9%).
Return on Equity
High ROE: MCO has a negative Return on Equity (-67.15%), as it is currently unprofitable.